Azabicyclic-substituted-heteroaryl compounds for the treatment of disease

   
   

The invention provides compounds of Formula I:

These compounds may be in the form of pharmaceutical salts or compositions, racemic mixtures, or pure enantiomers thereof. The compounds of Formula I are useful in pharmaceuticals in which 7 is known to be involved.

 
Web www.patentalert.com

< Amide derivatives as NMDA receptor antagonists

< N-substituted heterocyclic amines as modulators of chemokine receptor activity

> N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

> Cyclohexylamine derivative as subtype selective NMDA receptor antagonists

~ 00194